These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 9498600)

  • 1. Boron-11 NMR of borocaptate: relaxation and in vivo detection in melanoma-bearing mice.
    Bendel P; Frantz A; Zilberstein J; Kabalka GW; Salomon Y
    Magn Reson Med; 1998 Mar; 39(3):439-47. PubMed ID: 9498600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
    Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): a comparison between 1H and 10B NMR.
    Bendel P; Sauerwein W
    Med Phys; 2001 Feb; 28(2):178-83. PubMed ID: 11243341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
    J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy.
    Doi A; Kawabata S; Iida K; Yokoyama K; Kajimoto Y; Kuroiwa T; Shirakawa T; Kirihata M; Kasaoka S; Maruyama K; Kumada H; Sakurai Y; Masunaga S; Ono K; Miyatake S
    J Neurooncol; 2008 May; 87(3):287-94. PubMed ID: 18219552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of the neutron capture therapy agent BSH in mice using (10)B MRI.
    Bendel P; Koudinova N; Salomon Y
    Magn Reson Med; 2001 Jul; 46(1):13-7. PubMed ID: 11443705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant differences in the retention of the borocaptate monomer (BSH) and dimer (BSSB) in malignant cells.
    Elhanati G; Salomon Y; Bendel P
    Cancer Lett; 2001 Oct; 172(2):127-32. PubMed ID: 11566486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
    J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSH distributions in the canine head and a human patient using 11B MRI.
    Bradshaw KM; Schweizer MP; Glover GH; Hadley JR; Tippets R; Tang PP; Davis WL; Heilbrun MP; Johnson S; Ghanem T
    Magn Reson Med; 1995 Jul; 34(1):48-56. PubMed ID: 7674898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
    Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of boron neutron capture therapy using borocaptate sodium in combination with a tumor-selective vasoactive agent in mice.
    Ono K; Masunaga S; Kinashi Y; Takagaki M; Akaboshi M; Suzuki M; Baba H
    Jpn J Cancer Res; 1998 Mar; 89(3):334-40. PubMed ID: 9600129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
    Yoshida F; Yamamoto T; Nakai K; Zaboronok A; Matsuda M; Akutsu H; Ishikawa E; Shirakawa M; Matsumura A
    Appl Radiat Isot; 2014 Jun; 88():86-8. PubMed ID: 24731546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
    Gibson CR; Staubus AE; Barth RF; Yang W; Ferketich AK; Moeschberger MM
    J Neurooncol; 2003; 62(1-2):157-69. PubMed ID: 12749711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.